Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

According to a new study, models based on cancer registry data can help identify subsets of stage 1 melanoma patients with very low...

Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...

Researchers at Emory University in Atlanta have synthesized a novel molecule called indolium 1 that blocks the growth of melanoma cells,...

A pilot study of a new biopsy imaging system has shown high accuracy in diagnosing non-melanoma skin cancer in two minutes—substantially...

A new study has discovered that by inhibiting the key metabolic enzyme GCDH, melanoma cells can be selectively killed to halt tumour growth.

People with lighter skin tones may be more susceptible to melanoma not only due to a lack of UV-protective melanin, but because of a lack...

According to a new study, many melanoma in situ may not be harmful or require treatment and are overly diagnosed.